Caltagirone SpA (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price on Sep 20, 2024

Company Description

Caltagirone SpA, through its subsidiaries, engages in the cement manufacturing, media, real estate, and publishing activities.

It is involved the publication of Italian newspapers, internet content, and social press; cement, aggregates, concrete, and value-added products; and leasing, sale, enhancement, management, and maintenance of building apartments in residential areas.

The company also build projects, such as Fiera di Milano Rho-Pero, the Rome-Naples high-speed railway line and Line C.

The company was founded in 1892 and is based in Rome, Italy. Caltagirone SpA is a subsidiary of Finanziaria Italia 2005 SpA.

Caltagirone SpA
Calliditas Therapeutics AB logo
Country Italy
Founded 1892
IPO Date Jun 5, 2020
Industry Biotechnology
Sector Healthcare
Employees 3,749
CEO Renee Aguiar-Lucander

Contact Details

Address:
Via Barberini 28
Rome, 00187
Italy
Phone 39 06 45 41 22 00
Website caltagironespa.it

Stock Details

Ticker Symbol CALT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency EUR
IPO Price $19.50
CIK Code 0001795579
CUSIP Number 13124Q106
ISIN Number US13124Q1067
SIC Code 3241

Key Executives

Name Position
Renee Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Lars Stubberud Vice President of Technical Operations
Asa Hillsten Head of IR and Sustainability
Brian Gorman Group General Counsel
Sandra Frithiof Vice President of Human Resources
Ann-Kristin Myde BSc Head of Clinical Development and Vice President of Project Management
Dr. Richard S. Philipson M.D. Chief Medical Officer
Teona Johnson Head of US Marketing
David Ferraro Head of US Sales

Latest SEC Filings

Date Type Title
Sep 23, 2024 15F-12B Filing
Sep 23, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 20, 2024 25-NSE Filing
Sep 18, 2024 SC TO-T/A Filing
Sep 18, 2024 SC 14D9/A Filing
Sep 17, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 16, 2024 EFFECT Notice of Effectiveness
Sep 16, 2024 SC TO-T/A Filing
Sep 13, 2024 25 Filing
Sep 13, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments